Loading…
ANI Pharmaceuticals, Inc. is projected to rise to $91.64 by 2027, a +14% move from its current price of $80.43. ANIP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $79.27 | $80.46 | $81.67 | +0.04% |
| Aug 2 | $78.82 | $80.50 | $82.22 | +0.09% |
| Aug 3 | $78.48 | $80.53 | $82.64 | +0.13% |
| Aug 4 | $78.20 | $80.57 | $83.01 | +0.17% |
| Aug 5 | $77.95 | $80.60 | $83.34 | +0.21% |
| Aug 6 | $77.74 | $80.64 | $83.64 | +0.26% |
| Aug 7 | $77.55 | $80.67 | $83.92 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $77.55 | $80.67 | $83.92 | +0.30% |
| Week 2 | $76.51 | $80.91 | $85.56 | +0.60% |
| Week 3 | $75.79 | $81.15 | $86.90 | +0.90% |
| Week 4 | $75.21 | $81.40 | $88.09 | +1.20% |
| Week 5 | $74.74 | $81.64 | $89.18 | +1.50% |
| Week 6 | $74.33 | $81.88 | $90.20 | +1.81% |
| Week 7 | $73.98 | $82.13 | $91.17 | +2.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
The company operates within the Healthcare category and serves a range of national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers.
ANI Pharmaceuticals, Inc. trades under the symbol ANIP and is positioned in the Healthcare sector. The current price is $77.72, and the company has a market cap of $1.77B with a rank of 2018. The stock’s near-term technical backdrop shows it trading around a touch below key moving averages, with the 50-day MA at $81.28 and the 200-day MA at $81.74.
A major floor 9.5% below — a decisive break under it would weaken the trend.
The nearest floor, 3.5% below — buyers have tended to step in here.
The nearest ceiling, 7.0% above — a clean break opens room to run.
A major ceiling 11.6% above — clearing it would confirm fresh momentum.
Key ANIP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANIP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $79.85 | Buy | $80.22 | Buy |
| MA 10 | $79.15 | Buy | $80.05 | Buy |
| MA 20 | $81.18 | Sell | $80.52 | Sell |
| MA 50 | $81.14 | Sell | $80.75 | Sell |
| MA 100 | $79.39 | Buy | $80.45 | Sell |
| MA 200 | $81.29 | Sell | $79.57 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.10 | Neutral |
| Stoch RSI (14) | 74.00 | Neutral |
| CCI (20) | -22.66 | Neutral |
| Williams %R (14) | -34.57 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | -0.15 | Sell |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 65.43 | Neutral |
| TRIX (15) | -0.11 | Sell |
| Awesome (5,34) | -1.80 | Sell |
| Ultimate (7,14,28) | 53.00 | Neutral |
| Momentum (10) | -1.49 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 81.36 | Sell |
| ADX (14) | 12.28 | Neutral |
| ATR (14) | 1.25 | Info |
The current technical sentiment is NEUTRAL. The RSI(14) is 40, placing the stock in a neutral momentum zone. The stock sits near support at $77.72 and below resistance at $86.03, with the 50-day and 200-day moving averages near $81.28 and $81.74 respectively.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $70.49 | $80.43 | $107.33 | 0% | Neutral | |
| $75.14 | $91.64 | $116.80 | +14% | Neutral | |
| $86.26 | $107.21 | $140.39 | +33% | Bullish | |
| $96.49 | $121.79 | $162.91 | +51% | Bullish | |
| $113.84 | $145.63 | $198.34 | +81% | Bullish | |
| $131.32 | $170.06 | $235.30 | +111% | Bullish | |
| $138.63 | $181.57 | $254.81 | +126% | Bullish | |
| $149.46 | $197.82 | $281.22 | +146% | Bullish | |
| $155.55 | $207.93 | $299.15 | +159% | Bullish | |
| $161.33 | $217.71 | $316.71 | +171% | Bullish | |
| $245.79 | $345.97 | $527.49 | +330% | Bullish | |
| $501.70 | $757.42 | $1,238.06 | +842% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $70.49 | $80.43 | $93.73 | +0.00% |
| August 2026 | $71.51 | $83.39 | $99.09 | +3.68% |
| September 2026 | $71.30 | $83.62 | $100.30 | +0.27% |
| October 2026 | $71.29 | $83.99 | $101.49 | +0.45% |
| November 2026 | $73.28 | $86.66 | $105.35 | +3.18% |
| December 2026 | $74.00 | $87.81 | $107.33 | +1.32% |
Click any year to see its month-by-month ANIP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ANIP could reach as high as $107.33, with a base case around $80.43 and support toward $70.49 — roughly 0% from $80.43. A consolidation phase looks the most probable path here.
Expect ANIP to range from $75.14 to $116.80 through 2027. The $91.64 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. Price action looks broadly range-bound.
The ANIP price prediction for 2028 points to an average of $107.21 (low $86.26, high $140.39) — a potential gain of +33% on today's $80.43. Buyers look set to stay in control over this stretch.
In 2029, ANIP is projected to trade between $96.49 and $162.91, averaging $121.79 — a potential gain of +51% from today's $80.43. That is up +14% on the projected 2028 average. Momentum favours further upside here.
ANI Pharmaceuticals, Inc.'s 2030 outlook centres on $145.63, within a $113.84 to $198.34 range. That is up +20% on the projected 2029 average. That marks a +81% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, ANIP could reach as high as $235.30, with a base case around $170.06 and support toward $131.32 — roughly +111% from $80.43. Momentum favours further upside here.
Expect ANIP to range from $138.63 to $254.81 through 2032. The $181.57 average target implies a +126% move from current prices. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The ANIP price prediction for 2033 points to an average of $197.82 (low $149.46, high $281.22) — a potential gain of +146% on today's $80.43. Momentum favours further upside here.
In 2034, ANIP is projected to trade between $155.55 and $299.15, averaging $207.93 — a potential gain of +159% from today's $80.43. That is up +5% on the projected 2033 average. Buyers look set to stay in control over this stretch.
ANI Pharmaceuticals, Inc.'s 2035 outlook centres on $217.71, within a $161.33 to $316.71 range. That is up +5% on the projected 2034 average. That marks a +171% change versus current levels. Momentum favours further upside here.
By 2040, ANIP could reach as high as $527.49, with a base case around $345.97 and support toward $245.79 — roughly +330% from $80.43. Buyers look set to stay in control over this stretch.
Expect ANIP to range from $501.70 to $1,238.06 through 2050. The $757.42 average target implies a +842% move from current prices. That is up +119% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ANIP today (≈ 12.433172 ANIP) could be worth
$9,417.17
+$8,417.17 (+842%) by 2050 · US Dollar
Based on the average projected ANIP price of $757.42 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANIPwould be worth at today's price.
$1,000 invested in ANIP on Jul 30, 2025 (≈ 15.61768 ANIP) would be worth
$1,256.13
+$256.13 (+25.6%) today · 1.26× · US Dollar
Based on a ANIP entry price of $64.03 vs. today's $80.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $78.53 | $1,024.19 | +2.4% |
| 1 month ago | $82.78 | $971.61 | -2.8% |
| 3 months ago | $80.39 | $1,000.5 | +0.0% |
| 6 months ago | $81.85 | $982.65 | -1.7% |
| 1 year ago | $64.03 | $1,256.13 | +25.6% |
| All time (5.0y) ago | $33.37 | $2,410.25 | +141.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANIP forecast.
Our base-case forecast reaches $160.00 around 2031.
Implied market cap at $160.00: $3.64B
The multi-year forecast shows a bullish tilt beginning in the later part of the horizon, with the 2026 average price at $77.72 and the outlook rising to higher levels in subsequent years. The 2027 average is $87.18, the 2028 average is $102.32, and the 2029 average is $113.37, culminating in a 2030 average of $134.48 and a 2030 ROI of 73. By 2040 the average is projected at $310.48 (ROI 299.5), and by 2050 the average climbs to $656.61 (ROI 744.8), with clearly bullish sentiment through the period.
These are estimates and not guarantees, reflecting potential upside if the projected path materializes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $134.48 with a min of $105.08 and a max of $183.23, and a forecasted ROI of 73, with bullish sentiment.
Forecasts show a bullish trajectory from 2028 onward, with the average price rising from $102.32 in 2028 to $134.48 in 2030 and continuing higher through 2050, along with positive ROI (e.g., 73 by 2030 and 744.8 by 2050), though these are estimates and not guarantees.
Yes. The 2030 max in the forecast is $183.23, with a 2030 min of $105.08 and an average of $134.48.
Current price is $77.72 and market cap is $1.77B.
The sentiment is NEUTRAL, with RSI(14) at 40. The stock trades near support at $77.72 and resistance at $86.03, with 50-day SMA at $81.28 and 200-day SMA at $81.74 and a 30-day range of $70.43 to $85.76; annualized volatility is 30%.
ANI Pharmaceuticals, Inc. Community Discussion
0Share your ANI Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.